Lubrizol, Polyhose sign MoU to establish a medical facility in Chennai. This strategic partnership between Lubrizol, a global leader in speciality chemicals, and Polyhose, an expert in fluid conveyance systems, marks a significant move to bolster medical technology and production capabilities in India.
Lubrizol, Polyhose sign MoU for a new medical unit
The MoU between Lubrizol and Polyhose paves the way for constructing a medical tubing unit, set to begin in 2025 with operations starting in 2026. This facility will significantly increase Lubrizol’s production of medical tubing, ensuring easier access to life-saving equipment both in India and abroad. The high-quality tubing will support essential neurovascular and cardiovascular procedures, such as balloon and minimally invasive catheters.
Advanced solutions through Lubrizol and Polyhose collaboration
Lubrizol and Polyhose will employ advanced technology, using high-grade thermoplastic polyurethane (TPU) along with other polymers to produce the tubing. These materials offer exceptional biocompatibility and performance, ensuring patient comfort and safety. Additionally, the facility will comply with ISO 13485 standards, guaranteeing top-notch medical device manufacturing.
Strategic impact of the Lubrizol, Polyhose MoU
Rebecca Liebert, President and CEO of Lubrizol, emphasized the importance of this investment, stating that it positions India as an innovation hub and strengthens the country’s medical sector. She remarked, “With this MoU, we are poised to deliver world-class medical tubing, supporting both local and global needs.”
Investments boosted by the Lubrizol, Polyhose partnership
Lubrizol’s investments in India have surpassed $350 million in recent years. The company has launched a Global Capability Centre in Pune and plans a significant manufacturing facility in Aurangabad. Additionally, Lubrizol has expanded its CPVC production in Gujarat to meet the growing demand. Shabbir Y. J., Managing Director of Polyhose, highlighted the long-standing partnership with Lubrizol and noted that this MoU marks a pivotal point in their collaboration.
This agreement underscores India’s growing capability to produce high-quality, locally sourced medical devices that serve global healthcare markets.
